chrisvoncsefalvay/vaers-outcomes huggingface dataset:
24 hours after receiving the shot started having COVID-19 symptoms: achiness, chills, fever 103, dry mouth with metal taste, weak, loss of appetite, soreness under armpit (lymph node developed). Took Tylenol and Aleve felt better after sleeping 12 hours straight. I have had COVID-19 twice and the antibodies are in my  blood stream every time I go give blooded I receive a letter indicating such.
Mom stopped into clinic states child had immunizations 10/06/2003 in AM, child right upper leg red, warm, swollen size 5 cm x 5 cm, temperature 99.4. RN told childs mom to give Tylenol and apply warm and cold compresses if child becomes worse go to ER.  Called mom on 10/08/2003 she stated she went to ER in PM he gave child IM Benadryl today. Sates child swelling in leg better today 10/08/2003
Weakness, cold sweat, nausea, metallic/sour taste in mouth, salivation
FEW HOURS AFTER INJECTION FELT SHOOTING PAIN AND TINGLING SENSATION IN LEFT ARM THEN MOVED UNDER LEFT PEC AND RIGHT ARM. SYMPTOMS SUBSIDE BY NEXT DAY.
This spontaneous report was received from a physician via a company representative referring to a 12 year old patient. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 06-APR-2012, the patient was vaccinated with a dose of GARDASIL and a dose of VAQTA (strength, dose number, route, anatomical location, lot number and expiration date were not provided) for prophylaxis. On 06-APR-2012 (reported as: "later that day"), the patient developed a "rash on the arms, neck and back, an itchy throat and had trouble breathing. It was reported that the patient's mother gave BENADRYL at home for treatment, additionally the patient sought medical attention. At the time of the report, the outcome of dyspnoea, throat irritation and rash was reported as recovered on an unspecified date. The reporter did not assess the relatedness between the events and GARDASIL and of VAQTA. Additional information has been requested.
Pt stated 4 days after the covid vax he had gastro intestinal symptoms, pain in right foot, pain in the left arm under the elbow.  Joint pain in both wrist and both feet, pain in left knee. Pt states the gastro intestinal has been intensified in the past week.  Pt has left message w/ his PCP to discuss symptoms and if he needs to be seen.
This spontaneous report as received from a Healthcare worker refers to an unspecified number of patients of unknown age. The pertinent medical history and concurrent conditions of patients were not reported. On an unknown dates, the patients were vaccinated with incorrectly stored PROQUAD (Merck) lot # L040411, expiry date 13-APR-2017 (dose and route not reported). The vaccine was exposed to the temperature of -10 degree Centigrade for 10 days. There were no previous excursion reported. The reporting healthcare worker was not aware of any adverse events. No additional information was reported. This case is one of the several reports from same reporter. Additional information has been requested.
Extreme irregular heartbeat approximately 4 hours following vaccination. Significant palpitations persisted thru the evening and night.
Adult dose given. Dr. was notified. I informed patient's mother after the shot was given. No Adverse reaction reported.
Patient became lethargic, weak and generally debilitated with tremors and inability to complete ADLs without assistance, beginning on 4/7/21 (date of second dose of vaccine). She was taken to see a neurologist on 4/12/21. She showed some improvement by 5/5/21 but then had a recurrence of generalized decline and on 5/28/21 she became weak and fell while ambulating. On 5/29/21, she had another event with weakness and fall and was taken to the hospital and admitted.
Patients daughter called about an hour after they left the pharmacy reporting that her mother was very nauseous and was beginning to itch.  She stated that there were no hives yet and she was not experiencing any problems breathing nor had shortness of breath.  Advised patient to take benedryl/diphenhydramine take an easy, informed daughter that if she got worse or had problems breathing to go to the ER, also assured patient that I would call in an hour to check on them.  When I called back and 1:52pm, patient had taken diphenhydramine and an ondansetron she had at home and was feeling much better.  Still felt foggy, but there was no more itching nor was she nauseous.  Advised her to take an easy for the rest of the day, and patient herself reported feeling much better.
Left arm - loss of range of movement and strength.  Initially a knot in the upper trapezoid area developed prior to the loss of range movement in the arm.
PATIENT STATED THAT SYMPTOMS OF SORE ARM AND REDNESS DEVELOPED SOON AFTER THE VACCINATION ON 6/22/21,  GOT WORSE EACH DAY, SHE HAS REDNESS AND SLIGHT SWELLING AROUND INJECTION SITE, AND THE AREA FEELS WARM AND PAINFULL, SHE  SAW HER DOCTOR TODAY 6/25/21 AND WAS GIVEN SOME ALLERGY MEDICATION,
4 days p/vax pt reported that devel redness & irritation @ the inj site as well as numbness & little function of the third finger of lt hand;
No additional adverse events.; On 20-JUL-2020 a patient was administered an improperly stored VARIVAX; This spontaneous report was received from an office manager referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant therapies, and previous drug reaction, or allergies was not provided.  On 20-JUL-2020, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection (strength, dose, vaccination scheme frequency, route of administration, and anatomical location were not reported; lot number S035125, which have been verified to be valid, expiration date reported and validated as 04-NOV-2021) as prophylaxis (product storage error). It was reported that the sterile diluent (MERCK STERILE DILUENT) used to reconstitute the vaccine was properly stored (lot number and expiration date was not provided).  On 17-JUL-2020, the vaccine was stored in a temperatures of 6 degrees Fahrenheit (F) (9.0 degrees F) for 1 hour, from 15 degrees F to 46 degrees F (45.9 degrees F) for 10 hours and 30 minutes; and starting at 10:07 pm, in a temperature from -47 degrees F to 77 degrees F (77 degrees F) for 15 hours. On 18-JUL-2020, starting at 2:52 pm, the vaccine was stored in a temperature of -78 degrees F/26 degrees Celsius or warmer (79.5 degrees F) for 32 hours. There was no previous temperature excursion and a digital data logger was not involved. No adverse events were reported.
Post vax, he vomited several times and developed a temp of 102-103. She gave him a minimal amount of Tylenol, however, she noticed that he was walking unsteady. On exam, pt's nose was full of green mucus, his left ear was full of wax. His pulse was 130. He indicated tenderness in all quadrants of his abdomen but there was no reflex guarding or any sign of objective tenderness. However, again in the ER, he did vomit once. I think the pt is having a reaction to his IZ, more probably the DPT than anything else. He did get the shot polio, not the live oral one. However, mom was quite concerned and because this reaction seemed a little more severe than others, I decided to keep him in observation.
Pfizer 2/27/21, 3/27/21, 9/27/21, 3/31/22. Positive on 11/28/22
PT BELIEVES SHE DEVELOPED A RINGWORM INFECTION AFTER VACCINE ADMINISTRATION
caller has the flu currently; sore throat; This is a spontaneous report from a contactable consumer (patient) by a Pfizer-sponsored program.   A 46-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration on 13Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and  concomitant medications were not reported. The patient experienced flu currently and sore throat on an unspecified date. The patient underwent lab tests and procedures which included sars-cov-2 test negative on an unspecified date. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
6 hrs after shot was given the following side effects appeared:  100 degree fever, hot flashes/chills, shaking, chest pain, headache, joint aches. Numbness and loss of color in finger tips. Side effects lasted for 24 hrs. Fever broke within 3hrs of onset.
Right arm injection site has a bump; Right arm injection site is still sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Right arm injection site has a bump) and VACCINATION SITE PAIN (Right arm injection site is still sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2022, the patient experienced VACCINATION SITE MASS (Right arm injection site has a bump) and VACCINATION SITE PAIN (Right arm injection site is still sore). At the time of the report, VACCINATION SITE MASS (Right arm injection site has a bump) outcome was unknown and VACCINATION SITE PAIN (Right arm injection site is still sore) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was provided. The patient had right arm injection site was still sore and had a bump/swollen No treatment medication was provided.   Reporter did not allow further contact
Measles, Mumps and Rubella vaccine MMR II administered intramuscular instead of subcutaneously. Called and spoke with CDC and states does count.
About 15 minutes after getting the shot, felt numbness and tingling up the right side of face, nausea and light headed ness.  This got gradually worse but was able to drive to emergency room in time to be seen. Gave all the information to emergency room personnel and they gave benedryl and kept under observation.  Symptoms resolved completely 3 days following.  Followed up with primary care provider soon after.  Mixed advice on receiving the second dose. But decided to do it to finish the vaccine. Got second dose in left arm instead and had the same symptoms  but much milder, also on the right side of face. Did not report these after second dose because they were mild.
21FEB mom reports "high fever & irritable" pt given APAP; 22FEB pt had seizure & mom called 911; taken to ER seen by MD t41.4 R; P168, R48 (vitals taken while crying); dx w/high fever & grand mal seizure p/DTP; tx w/APAP, & Advil;
Really weird adverse reaction/weird side effect; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Really weird adverse reaction/weird side effect) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Really weird adverse reaction/weird side effect). At the time of the report, VACCINATION COMPLICATION (Really weird adverse reaction/weird side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported.  Treatment medication were not reported.  Patient got the Moderna vaccine Saturday morning and was having a really weird adverse reaction, a weird side effect.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 15-OCT-2015, the patient was vaccinated with improperly stored RECOMBIVAX HB (exposed to the following temperatures and cumulative time frames colder than 36F: In September of 2015, the coldest temperature was 34F for 346.7 hours (over 14 days); In October of 2015, the coldest temperature was 34F for 492.6 hours for a total of 839.3 hours (35 days); In November of 2015, the coldest temperature was 34F for 192 hours, for a total of 1,031.3 hours (43 days)) with lot number: L010595, expiry date: 12-NOV-2016 (dose and strength unspecified). No concomitant medications were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
My left side, I got the shot on the left arm, so my left side, lower back pain; Left leg is numb; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01May2021 (Batch/Lot number: unknown) at the age of 42 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Low on iron" (unspecified if ongoing), notes: Verbatim: Low on iron. Concomitant medication(s) included: FERRO SANOL DUODENAL taken for blood iron decreased. The following information was reported: BACK PAIN (non-serious) with onset 03May2021, outcome "unknown", described as "My left side, I got the shot on the left arm, so my left side, lower back pain"; HYPOAESTHESIA (non-serious) with onset May2021, outcome "unknown", described as "Left leg is numb".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a registered nurse refers to a 70 year old female patient with diabetes and an unspecified heart disease. The patient's historical condition was not reported. There was no illness at time of vaccination. Concomitant therapies included FLUARIX and sterile diluent. On 11-OCT-2017, the patient was vaccinated with an improperly stored first dose of ZOSTAVAX with lot # M041511 and expiration date of 08-JAN-2018, subcutaneously in the right deltoid (strength and dose were unknown) for prophylaxis, which was stored from -9 Celsius degrees (°C) to 8°C (-3.3°C) for 5 hours and 45 minutes. There was no previous temperature excursion. Moreover, it was reported that the temperature excursions were detected by a data logger. No adverse effects were reported. This is one of two cases received from the same reporter. Sender's Comments: US-009507513-1710USA015410.
Swelling and pain at injection site, tingling and numbness of fingers Narrative:  Per nursing report:  "1st dose of COVID 19 on 2/8/21 at 10am. Work up [2/9] with swelling and pain in his left arm. Employee report tingling in his left hand and fingers. Vital signs are stable."  Other Relevant History:
All outlined in my VSafe health checkin today. Injection site pain.  Chills, headache, joint pain, fever, muscle aches, fatigue, nausea, vomiting, diarrhea, abdominal pain, fibromyalgia flare up, anxiety and depression. Started around 6pm on 1/18 and began to ease up on 1/23 in the evening.
24 hours following vaccination the pt spiked a fever up to 106, was not responsive to acetaminophen, ibuprofen, baths. The pt then had a febrile seizure.
pain; muscle aches; rise with his proBNP which went up to 4000; This spontaneous case was reported by a nurse and describes the occurrence of N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED (rise with his proBNP which went up to 4000), PAIN (pain) and MYALGIA (muscle aches) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Congestive heart failure.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED (rise with his proBNP which went up to 4000). On an unknown date, the patient experienced PAIN (pain) and MYALGIA (muscle aches). On 10-Mar-2021, N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED (rise with his proBNP which went up to 4000) had resolved. At the time of the report, PAIN (pain) and MYALGIA (muscle aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, N-terminal prohormone brain natriuretic peptide: 4000 (High) rise. On 10-Mar-2021, N-terminal prohormone brain natriuretic peptide: 2000 (Inconclusive) 2000 (went back down to what it was before he took the vaccination which was 2000).     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported. Action taken with mRNA-1273 in response to the events was not applicable.
This spontaneous retrospective pregnancy report as received from a pharmacist refers to a 22 year old female patient who was participated in a Market research program. Concurrent condition and medical history were not reported. On an unknown date in August 2014 the patient was vaccinated with a dose of VARIVAX (Merck) (lot#, expiration date, dose and route were unknown), and the patient discovered her pregnancy 1 week later after the vaccination. The patient's last menstrual period (LMP), estimated date of delivery and pregnancy outcome were unknown. The outcome of exposure during pregnancy was reported as recovered/resolved on an unknown date. The reporter considered the event was serious. Additional information is not expected as the reporter was not willing to be contacted.
Received vaccine on 1/9/21.  On 1/16/21 started with drooping to eyelid.  On 1/21/21 experienced vertigo.  She was evaluated by her primary care doctor for those symptoms and was diagnosed with Bells Palsy at that time, and with vertigo. Her PMD recommended she not go forth with the 2nd dose of the vaccine.
Presyncopal event 15 minutes after receiving vaccine lasted about 10-15 seconds. Reclined in chair and given juice and water. Resolved quickly and observed for additional minutes without any symptoms.
CHEST TIGHTNESS; LOWER JAW PAIN; This spontaneous report received from a patient concerned a 55 year old female. The patient's weight was 135 pounds, and height was 161.54 centimeters. The patient's concurrent conditions included polysorbate 80 and oxalate sensitivity.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022,  expiry: 25/MAY/2021) dose was not reported, On 15-MAR-2021 administered on Left arm for covid-19 virus prevention. No concomitant medications were reported. On 17-MAR-2021, the subject experienced chest tightness. On 17-MAR-2021, the subject experienced lower jaw pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chest tightness, and lower jaw pain on 19-MAR-2021. This report was non-serious.
This spontaneous report was received from a Licensed Practical Nurse refers to a 64 year old male patient. The patient had no pertinent medical history and no drug reactions/allergies. On 09-SEP-2013 the patient was vaccinated with a dose of ZOSTAVAX (lot # unspecified) (dose, route and location unspecified). Concomitant therapies included with LEXAPRO, LOVAZA, and vitamin E. On 09-SEP-2013 the patient was developed body aches, fever, malaise and rash on his legs and left thorax after receiving a dose of ZOSTAVAX on 09-SEP-2013 at a pharmacy. The patient was seen by his physician on 10-SEP-2013 and instructed to rest and increase his fluids. No lab diagnostic study was performed. At the time of report, the outcome of the events was not provided. Additional information has been requested.
Patient received 2nd dose of Moderna.  He was placed in the WR.  After about 5 minutes he starting complaining of throbbing headache and would drift off and about to fall out of chair.  NP was called and she assessed patient.  Glucose was obtained it was 107. He is diabetic.  Per , an ambulance was called.  When ambulance techs arrived, patient refused to leave in/with the ambulance.  After about 30 minutes he left with  (lives with her).  Instructed to call or seek medical attention should anything change.
Localized redness to right deltoid, not raised, size: 70mm x 80mm. No fever.
Received Flu injection at 8am on 10/8/02. On 10/11/02 at 8:30am I became very hot and my skin felt like I was on fire/upon looking in the mirror. I was as red as a beet. I felt like hot led pouring all over me-this lasted 45mins. It happened again on 10/12/02 and again on 10/13/02 and last on 10/14/02.
Nurse gave Varicella Vaccine instead of Vaxelis Vaccine ordered by provider. Provider notified and to call patient's mom. Patient to come back to clinic in 3 weeks for correct vaccine.
C/O ITCHING IN RT ANTICUBITAL, THEN LEFT WITH ERYTHEMA, HIVES, WHEAL AND ITCHINESS ON BACK AND FRONT OF TORSO.  NO DIFFICULTY BREATHING.  50 MG BENADRYL GIVEN IM, SYMPTOMS SUBSIDED IN 20 MINUTES.
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from a practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 30-MAY-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (strength and route were unknown) (lot# N020353 and expiration date 28-APR-2020) for prophylaxis (Incorrect product storage). No adverse event was reported. The excursion temperature on 08-NOV-2017, 16-NOV-2017, 23-JAN-2018, 06-JUN-2018, 03-JUL-2018 and 14-AUG-2018   was 47 degree Celsius for maximize 15 hours. The excursion temperature on 07-DEC-2017 was 50 degree Celsius for maximize 8.75 hours. The call was not because of data logger. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001957: US-009507513-1810USA001958: US-009507513-1810USA001959: US-009507513-1809USA003709.
This case was reported in a literature article and described the occurrence of Guillain Barre syndrome in a 6-year-old male subject who was vaccinated with influenza vaccine unspecified (manufacturer unspecified). On an unspecified date, the subject received an unspecified dose of influenza vaccine unspecified (administration site and route unknown, batch number not provided). 10 days after vaccination with influenza vaccine unspecified, the subject experienced collapse (unconscious), cough, fever, limping, headache, back pain and low extremity weakness. The subject was hospitalised. A lumbar puncture was performed and the diagnosis of Guillain-Barre syndrome was made. The subject was treated with normal immunoglobulin during 5 days but it was still noted to have impaired motor function, left greater than right, with intact sensation in bilateral lower extremities. 3 weeks after diagnosis, the subject was admitted to acute inpatient rehab secondary to his inability to ambulate. While in rehab, the subject underwent electromyogram which was consisted with severe axonal motor neuropathy which is a variant of Guillain-Barre syndrome. At the time of discharge, 12 weeks after admission to acute inpatient rehab, the subject was able to ambulate a distance of 15 feet using a posterior walker utilizing bilateral hip-knee-ankle-foot-orthoses requiring moderate level of assistance. He was able to transfer with supervision and performed activities of daily living with minimal assist.